APA (7th ed.) Citation

Deng, M., Sill, M., Schittenhelm, J. F., Ebinger, M., Schuhmann, M. U., Monoranu, C. M., . . . Jones, D. T. W. (2018). Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta neuropathologica, 136(2), . https://doi.org/10.1007/s00401-018-1865-4

Chicago Style (17th ed.) Citation

Deng, Maximilian, et al. "Molecularly Defined Diffuse Leptomeningeal Glioneuronal Tumor (DLGNT) Comprises Two Subgroups with Distinct Clinical and Genetic Features." Acta Neuropathologica 136, no. 2 (2018). https://doi.org/10.1007/s00401-018-1865-4.

MLA (9th ed.) Citation

Deng, Maximilian, et al. "Molecularly Defined Diffuse Leptomeningeal Glioneuronal Tumor (DLGNT) Comprises Two Subgroups with Distinct Clinical and Genetic Features." Acta Neuropathologica, vol. 136, no. 2, 2018, https://doi.org/10.1007/s00401-018-1865-4.